NCT07754214 Outcomes of the Proprioception and Strengthening Exercise Program in Chronic Plantar Fasciitis
| NCT ID | NCT07754214 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karamanoğlu Mehmetbey University |
| Condition | Plantar Fasciitis, Chronic |
| Study Type | INTERVENTIONAL |
| Enrollment | 105 participants |
| Start Date | 2026-08-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 105 participants in total. It began in 2026-08-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Plantar fasciitis is a common cause of heel pain, and although stretching exercises are a standard first-line treatment, current evidence on adding proprioception or knee-strengthening exercises remains limited. This study investigates whether adding knee strengthening or proprioception exercises to a standard stretching program improves pain, function, and disability in patients with chronic plantar fasciitis, and whether these interventions produce measurable changes in the biomechanical and kinesiological properties of the foot, ankle, and knee.
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 65 years. * Formal diagnosis of plantar fasciitis, characterized by sharp pain during the first steps in the morning, pain that increases with prolonged activity, localized tenderness on palpation of the medial calcaneal tubercle or proximal fascia, and a positive Windlass test. * Symptom duration of at least 3 months. * Heel pain intensity score of Visual Analog Scale (VAS) \> 3. * Voluntary agreement to participate, evidenced by signing the written informed consent form. Exclusion Criteria: * History of acute lower-extremity trauma. * History of prior foot or ankle surgery. * Corticosteroid injection to the affected heel within the preceding 6 months. * Presence of systemic inflammatory or rheumatologic disease. * Uncontrolled systemic disease (e.g., uncontrolled hypertension, uncontrolled diabetes mellitus). * Current or past history of malignancy. * Current pregnancy. * Body mass index (BMI) ≥ 30 kg/m². * Any musculoskeletal, neuromuscular, ocular, or vestibular disorder that could impair balance or limit the ability to stand unsupported. * Neurocognitive or psychiatric conditions precluding adherence to the exercise protocols or outcome assessments.
Contact & Investigator
Aynur Basaran, MD, Prof.
PRINCIPAL INVESTIGATOR
Karamanoğlu Mehmetbey University
Frequently Asked Questions
Who can join the NCT07754214 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Plantar Fasciitis, Chronic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07754214 currently recruiting?
Yes, NCT07754214 is actively recruiting participants. Contact the research team at sulekosar@kmu.edu.tr for enrollment information.
Where is the NCT07754214 trial being conducted?
This trial is being conducted at Karaman, Turkey (Türkiye).
Who is sponsoring the NCT07754214 clinical trial?
NCT07754214 is sponsored by Karamanoğlu Mehmetbey University. The principal investigator is Aynur Basaran, MD, Prof. at Karamanoğlu Mehmetbey University. The trial plans to enroll 105 participants.